Skip to main content
. Author manuscript; available in PMC: 2022 Jul 6.
Published in final edited form as: Stat Biopharm Res. 2021 Jul 6;13(3):260–269. doi: 10.1080/19466315.2021.1927824

Table 1.

A summary of the PH, PM, and PW models for composite endpoints of ND(·) and N(·).

Rule of univariatization
PH F(Y)(t)=I{ND(t)+N(t)1}
PM R(Y)(t)=ND(t)+N(t)
PW W(Yi,Yj)(t)=I(Dj<Dit)+I(DiDj>t,Tj<Tit).
Modeling target (k = 1, 0)
PH Hazard function: λk(t)=E{F(Y)(dt)F(Y)(t)=0,Z=k}/dt
PM Mean function: μk(t)=E{R(Y)(t)Z=k}
PW Win-loss function: ωk(t)=E{W(Yi,Yj)(t)Zi=k,Zj=1k}
Model assumption
PH λ1(t) / λ0 (t) ≡ exp(β)
PM μ1 (t) / μ0 (t) ≡ exp(β)
PW ω0 (t) / ω1 (t) ≡ exp(β)
Estimand & Interpretation
PH Hazard ratio: Treatment exp(β) times as likely to experience first event
PM Mean ratio: Treatment experiencing exp(β) times as many events
PW Loss ratio: Treatment exp(β) times as likely to produce worse outcome
adjusting for priority of death over non-fatal events
Accounting for semi-competing risks
PH Not needed
PM Inverse probability censoring weighting
PW Not needed if death is hierarchically prioritized
R-function
PH survival::coxph
PM Wcompo::CompoML
PW WR::pwreg